Drug
MI paste
Total Trials
2
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
1
50%
Ph not_applicable
1
50%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Other(1)
Detailed Status
unknown1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 11 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown150%
enrolling_by_invitation150%
Recent Activity
0 active trials
Showing 2 of 2
enrolling_by_invitationnot_applicable
Microbiome Effects of Extended Use of MI Paste in Elderly Removable Denture Wearers
NCT06406751
unknownphase_1
Clinical Evaluation of the Efficacy of SPR-G Barrier Coat Versus Fluoride Varnish Versus MI Paste in the Treatment of Early White Spot Lesions in Pediatric Patients
NCT05202821
Clinical Trials (2)
Showing 2 of 2 trials
NCT06406751Not Applicable
Microbiome Effects of Extended Use of MI Paste in Elderly Removable Denture Wearers
NCT05202821Phase 1
Clinical Evaluation of the Efficacy of SPR-G Barrier Coat Versus Fluoride Varnish Versus MI Paste in the Treatment of Early White Spot Lesions in Pediatric Patients
All 2 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 2